Meena S. Moran

14.3k total citations · 1 hit paper
147 papers, 5.2k citations indexed

About

Meena S. Moran is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Meena S. Moran has authored 147 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Cancer Research, 70 papers in Oncology and 61 papers in Pathology and Forensic Medicine. Recurrent topics in Meena S. Moran's work include Breast Cancer Treatment Studies (102 papers), Breast Lesions and Carcinomas (53 papers) and Breast Implant and Reconstruction (31 papers). Meena S. Moran is often cited by papers focused on Breast Cancer Treatment Studies (102 papers), Breast Lesions and Carcinomas (53 papers) and Breast Implant and Reconstruction (31 papers). Meena S. Moran collaborates with scholars based in United States, China and Canada. Meena S. Moran's co-authors include Bruce G. Haffty, Qifeng Yang, Stuart J. Schnitt, Mariana Chávez‐MacGregor, Janet K. Horton, Monica Morrow, Nehmat Houssami, Jay R. Harris, Gary M. Freedman and Armando E. Giuliano and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Meena S. Moran

138 papers receiving 5.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer

2014 451 citations Meena S. Moran, Stuart J. Schnitt et al. Annals of Surgical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meena S. Moran United States	36	3.0k	2.0k	1.7k	1.3k	716	147	5.2k
Chindo Hicks United States	18	3.2k 1.1×	1.7k 0.9×	1.4k 0.8×	1.0k 0.8×	887 1.2×	80	5.3k
Mehra Golshan United States	41	3.9k 1.3×	3.2k 1.6×	1.9k 1.2×	1.5k 1.2×	744 1.0×	176	6.3k
Anees B. Chagpar United States	38	2.8k 0.9×	2.3k 1.2×	1.6k 1.0×	1.3k 1.0×	390 0.5×	223	5.2k
Christina Davies Australia	16	3.9k 1.3×	2.5k 1.3×	1.5k 0.9×	1.1k 0.9×	629 0.9×	53	6.9k
Charles E. Cox United States	45	3.3k 1.1×	2.7k 1.4×	2.6k 1.6×	2.0k 1.6×	662 0.9×	116	6.7k
Niels Kroman Denmark	39	1.7k 0.6×	2.8k 1.4×	842 0.5×	1.4k 1.1×	400 0.6×	167	5.3k
S. Ashley United Kingdom	47	2.0k 0.7×	3.1k 1.6×	1.1k 0.7×	827 0.7×	679 0.9×	127	7.1k
Karl von Smitten Finland	36	1.1k 0.4×	1.4k 0.7×	583 0.3×	1.2k 0.9×	741 1.0×	99	3.7k
Tari A. King United States	48	5.6k 1.9×	3.9k 2.0×	3.0k 1.8×	2.1k 1.7×	1.7k 2.4×	288	9.4k
Byeong‐Woo Park South Korea	42	2.4k 0.8×	2.4k 1.2×	1.5k 0.9×	801 0.6×	1.0k 1.4×	210	5.3k

Countries citing papers authored by Meena S. Moran

Since Specialization

Citations

This map shows the geographic impact of Meena S. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meena S. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meena S. Moran more than expected).

Fields of papers citing papers by Meena S. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meena S. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meena S. Moran. The network helps show where Meena S. Moran may publish in the future.

Co-authorship network of co-authors of Meena S. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Meena S. Moran. A scholar is included among the top collaborators of Meena S. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meena S. Moran. Meena S. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marta, Gustavo Nader, et al.. (2024). Underuse of Postoperative Radiation After Nipple-Sparing Mastectomy for Standard Radiation Indications. Advances in Radiation Oncology. 9(9). 101569–101569.

Yao, Katharine, Deanna J. Attai, Richard J. Bleicher, et al.. (2021). Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study). Breast Cancer Research and Treatment. 186(3). 625–635. 15 indexed citations

Zhang, Hanwen, Ning Zhang, Meena S. Moran, et al.. (2020). Special subtypes with favorable prognosis in breast cancer: A registry-based cohort study and network meta-analysis. Cancer Treatment Reviews. 91. 102108–102108. 14 indexed citations

Dietz, Jill R., Meena S. Moran, Steven J. Isakoff, et al.. (2020). Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Research and Treatment. 181(3). 487–497. 258 indexed citations

Kole, Adam J., Henry S. Park, Skyler B. Johnson, et al.. (2019). Overall survival is improved when DCIS accompanies invasive breast cancer. Scientific Reports. 9(1). 9934–9934. 22 indexed citations

Zhang, Ning, Hanwen Zhang, Ying Liu, et al.. (2018). SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. Cell Death and Differentiation. 26(5). 843–859. 151 indexed citations

Belkacémi, Yazid, Pauline T. Truong, Atif J. Khan, et al.. (2017). Adjuvant nodal radiotherapy in the era of sentinel node biopsy staging of breast cancer: A review of published guidelines and prospective trials and their implications on clinical practice. Critical Reviews in Oncology/Hematology. 112. 171–178. 4 indexed citations

Kole, Adam J., et al.. (2017). Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer Targets and Therapy. Volume 9. 313–323. 109 indexed citations

Chagpar, Anees B., Christos Hatzis, Lajos Pusztai, et al.. (2017). Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer. Annals of Surgical Oncology. 24(10). 3073–3081. 35 indexed citations

10.

Morrow, Monica, Kimberly J. Van Zee, Lawrence J. Solin, et al.. (2016). Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ. Annals of Surgical Oncology. 23(12). 3801–3810. 187 indexed citations

11.

Khan, Atif J., Sarah A. Milgrom, Nicola Barnard, et al.. (2014). Basal Subtype, as Approximated by Triple-Negative Phenotype, is Associated with Locoregional Recurrence in a Case–Control Study of Women with 0–3 Positive Lymph Nodes After Mastectomy. Annals of Surgical Oncology. 21(6). 1963–1968. 4 indexed citations

12.

Moran, Meena S., Stuart J. Schnitt, Armando E. Giuliano, et al.. (2014). Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. Journal of Clinical Oncology. 32(14). 1507–1515. 285 indexed citations

13.

Halyard, Michele Y., Eleanor Harris, Lisa Bailey, et al.. (2014). ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.. PubMed. 28(2). 157–64, C3. 2 indexed citations

14.

Zhu, Jiang, Xiaoyan Li, Xiangnan Kong, et al.. (2012). Testin is a tumor suppressor and prognostic marker in breast cancer. Cancer Science. 103(12). 2092–2101. 35 indexed citations

15.

Haffty, Bruce G., Hao Wu, Qifeng Yang, et al.. (2012). Low p53 Binding Protein 1 (53BP1) Expression Is Associated With Increased Local Recurrence in Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 83(5). e677–e683. 30 indexed citations

16.

Halyard, Michele Y., Nabil Wasif, Eleanor Harris, et al.. (2012). ACR Appropriateness Criteria® Local-regional Recurrence (LR) and Salvage Surgery. American Journal of Clinical Oncology. 35(2). 178–182. 9 indexed citations

17.

Goyal, Sharad, et al.. (2011). Interferon-induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT). International Journal of Radiation Oncology*Biology*Physics. 81(2). S214–S214. 1 indexed citations

18.

Khan, Atif J., Meena S. Moran, Kim M. Hirshfield, et al.. (2010). Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer. Journal of Immigrant and Minority Health. 13(1). 42–48. 3 indexed citations

19.

Patel, Akshar N., Sharad Goyal, Hao Wu, et al.. (2010). Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Research and Treatment. 126(3). 601–607. 21 indexed citations

20.

Haffty, Bruce G., Doo Ho Choi, Sharad Goyal, et al.. (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals of Oncology. 20(10). 1653–1659. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact